Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anne Nicholson-Weller, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AI042987 (NICHOLSON-WELLER, ANNE) Sep 30, 1998 - Feb 29, 2008
    CRI (CD35) As a Cellular Receptor for CIq
    Role: Principal Investigator
  2. R01HL033768 (NICHOLSON-WELLER, ANNE) Jul 1, 1984 - Nov 30, 2002
    Role: Principal Investigator
  3. R01DK034028 (NICHOLSON-WELLER, ANNE) Dec 1, 1983 - Jun 30, 1998
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Garg N, Zhang Y, Nicholson-Weller A, Khankin EV, Borsa NG, Meyer NC, McDermott S, Stillman IE, Rennke HG, Smith RJ, Pavlakis M. C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab. Nephrol Dial Transplant. 2018 12 01; 33(12):2260-2265. PMID: 29370420.
    Citations: 8     Fields:    Translation:Humans
  2. Melhorn MI, Brodsky AS, Estanislau J, Khoory JA, Illigens B, Hamachi I, Kurishita Y, Fraser AD, Nicholson-Weller A, Dolmatova E, Duffy HS, Ghiran IC. CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process. J Biol Chem. 2013 Oct 25; 288(43):31139-53. PMID: 24022490.
    Citations: 18     Fields:    Translation:HumansCellsCTClinical Trials
  3. Nicholson-Weller A. Hematology and diabetes: from hemoglobin A1c to CD59 glycation. Am J Hematol. 2013 Aug; 88(8):633. PMID: 23757192.
    Citations:    Fields:    Translation:HumansAnimals
  4. Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor. Cell Rep. 2013 Feb 21; 3(2):371-85. PMID: 23416052.
    Citations: 50     Fields:    Translation:HumansCells
  5. Keenan BT, Shulman JM, Chibnik LB, Raj T, Tran D, Sabuncu MR, Allen AN, Corneveaux JJ, Hardy JA, Huentelman MJ, Lemere CA, Myers AJ, Nicholson-Weller A, Reiman EM, Evans DA, Bennett DA, De Jager PL. A coding variant in CR1 interacts with APOE-e4 to influence cognitive decline. Hum Mol Genet. 2012 May 15; 21(10):2377-88. PMID: 22343410.
    Citations: 53     Fields:    Translation:Humans
  6. Glodek AM, Mirchev R, Golan DE, Khoory JA, Burns JM, Shevkoplyas SS, Nicholson-Weller A, Ghiran IC. Ligation of complement receptor 1 increases erythrocyte membrane deformability. Blood. 2010 Dec 23; 116(26):6063-71. PMID: 20861458.
    Citations: 21     Fields:    Translation:HumansCells
  7. Karnchanaphanurach P, Mirchev R, Ghiran I, Asara JM, Papahadjopoulos-Sternberg B, Nicholson-Weller A, Golan DE. C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex. J Clin Invest. 2009 Apr; 119(4):788-801. PMID: 19258706.
    Citations: 23     Fields:    Translation:HumansCells
  8. Ghiran I, Glodek AM, Weaver G, Klickstein LB, Nicholson-Weller A. Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1. Blood. 2008 Oct 15; 112(8):3465-73. PMID: 18684861.
    Citations: 14     Fields:    Translation:HumansCells
  9. Costa M, Ghiran I, Peng CK, Nicholson-Weller A, Goldberger AL. Complex dynamics of human red blood cell flickering: alterations with in vivo aging. Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Aug; 78(2 Pt 1):020901. PMID: 18850779.
    Citations: 26     Fields:    Translation:HumansCells
  10. Chen CH, Ghiran I, Beurskens FJ, Weaver G, Vincent JA, Nicholson-Weller A, Klickstein LB. Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35). Clin Exp Immunol. 2007 Jun; 148(3):546-54. PMID: 17493021.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  11. Honczarenko M, Ratajczak MZ, Nicholson-Weller A, Silberstein LE. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. J Immunol. 2005 Sep 15; 175(6):3698-706. PMID: 16148115.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  12. Honczarenko M, Lu B, Nicholson-Weller A, Gerard NP, Silberstein LE, Gerard C. C5L2 receptor is not involved in C3a / C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12. Leukemia. 2005 Sep; 19(9):1682-3; author reply 1684-5. PMID: 15990859.
    Citations: 8     Fields:    Translation:AnimalsCells
  13. Pilsczek FH, Nicholson-Weller A, Ghiran I. Phagocytosis of Salmonella montevideo by human neutrophils: immune adherence increases phagocytosis, whereas the bacterial surface determines the route of intracellular processing. J Infect Dis. 2005 Jul 15; 192(2):200-9. PMID: 15962214.
    Citations: 3     Fields:    Translation:HumansCells
  14. Watts A, Ke D, Wang Q, Pillay A, Nicholson-Weller A, Lee JC. Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect Immun. 2005 Jun; 73(6):3502-11. PMID: 15908379.
    Citations: 61     Fields:    Translation:AnimalsCells
  15. Repik A, Pincus SE, Ghiran I, Nicholson-Weller A, Asher DR, Cerny AM, Casey LS, Jones SM, Jones SN, Mohamed N, Klickstein LB, Spitalny G, Finberg RW. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin Exp Immunol. 2005 May; 140(2):230-40. PMID: 15807846.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  16. Otabor I, Tyagi S, Beurskens FJ, Ghiran I, Schwab P, Nicholson-Weller A, Klickstein LB. A role for lipid rafts in C1q-triggered O2- generation by human neutrophils. Mol Immunol. 2004 Jun; 41(2-3):185-90. PMID: 15159064.
    Citations: 4     Fields:    Translation:HumansCells
  17. Levy O, Jean-Jacques RM, Cywes C, Sisson RB, Zarember KA, Godowski PJ, Christianson JL, Guttormsen HK, Carroll MC, Nicholson-Weller A, Wessels MR. Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release. Infect Immun. 2003 Nov; 71(11):6344-53. PMID: 14573654.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  18. Ghiran I, Klickstein LB, Nicholson-Weller A. Calreticulin is at the surface of circulating neutrophils and uses CD59 as an adaptor molecule. J Biol Chem. 2003 Jun 06; 278(23):21024-31. PMID: 12646570.
    Citations: 25     Fields:    Translation:HumansCells
  19. Ghiran I, Tyagi SR, Klickstein LB, Nicholson-Weller A. Expression and function of C1q receptors and C1q binding proteins at the cell surface. Immunobiology. 2002 Sep; 205(4-5):407-20. PMID: 12396003.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  20. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med. 2000 Dec 18; 192(12):1797-808. PMID: 11120776.
    Citations: 68     Fields:    Translation:HumansCells
  21. Morgan BP, Daha M, Meri S, Nicholson-Weller A. Into the third century of complement research. Immunol Today. 2000 Dec; 21(12):603-5. PMID: 11188795.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  22. Tyagi S, Klickstein LB, Nicholson-Weller A. C5a-stimulated human neutrophils use a subset of beta2 integrins to support the adhesion-dependent phase of superoxide production. J Leukoc Biol. 2000 Nov; 68(5):679-86. PMID: 11073107.
    Citations: 6     Fields:    Translation:HumansCells
  23. Tyagi S, Nicholson-Weller A, Barbashov SF, Tas SW, Klickstein LB. Intercellular adhesion molecule 1 and beta2 integrins in C1q-stimulated superoxide production by human neutrophils: an example of a general regulatory mechanism governing acute inflammation. Arthritis Rheum. 2000 Oct; 43(10):2248-59. PMID: 11037884.
    Citations: 1     Fields:    Translation:HumansCells
  24. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J Immunol. 1999 Nov 01; 163(9):5056-63. PMID: 10528211.
    Citations: 26     Fields:    Translation:HumansCells
  25. Butko P, Nicholson-Weller A, Wessels MR. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J Immunol. 1999 Sep 01; 163(5):2761-8. PMID: 10453019.
    Citations: 17     Fields:    Translation:HumansCells
  26. Mondragón-Palomino M, Piñero D, Nicholson-Weller A, Laclette JP. Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9. J Mol Evol. 1999 Aug; 49(2):282-9. PMID: 10441679.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  27. Wang C, Bozza PT, Barbashov SF, Sauty A, Nicholson-Weller A. In vitro and in vivo responses of murine granulocytes to human complement-derived, haemolytically inactive C5b67 (iC5b67). Clin Exp Immunol. 1999 Aug; 117(2):261-8. PMID: 10444256.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  28. Nicholson-Weller A, Klickstein LB. C1q-binding proteins and C1q receptors. Curr Opin Immunol. 1999 Feb; 11(1):42-6. PMID: 10047536.
    Citations: 11     Fields:    Translation:Humans
  29. Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity. 1997 Sep; 7(3):345-55. PMID: 9324355.
    Citations: 63     Fields:    Translation:HumansCells
  30. Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD, Rosen FS, Carroll MC. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol. 1997 Jul 15; 159(2):976-82. PMID: 9218619.
    Citations: 20     Fields:    Translation:Animals
  31. Barbashov SF, Wang C, Nicholson-Weller A. Serum amyloid P component forms a stable complex with human C5b6. J Immunol. 1997 Apr 15; 158(8):3830-5. PMID: 9103450.
    Citations: 1     Fields:    Translation:HumansCells
  32. Butko P, Nicholson-Weller A, Wessels MR. Role of complement and complement receptor C1qR in the antibody-independent killing of group B streptococcus. Adv Exp Med Biol. 1997; 418:941-3. PMID: 9331805.
    Citations:    Fields:    Translation:HumansCells
  33. Wang C, Gerard NP, Nicholson-Weller A. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes. J Immunol. 1996 Jan 15; 156(2):786-92. PMID: 8543834.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  34. Wang C, Barbashov S, Jack RM, Barrett T, Weller PF, Nicholson-Weller A. Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Blood. 1995 May 01; 85(9):2570-8. PMID: 7727785.
    Citations: 4     Fields:    Translation:HumansCells
  35. Jack RM, Lowenstein BA, Nicholson-Weller A. Regulation of C1q receptor expression on human polymorphonuclear leukocytes. J Immunol. 1994 Jul 01; 153(1):262-9. PMID: 7911495.
    Citations: 5     Fields:    Translation:HumansCells
  36. Nicholson-Weller A, Wang CE. Structure and function of decay accelerating factor CD55. J Lab Clin Med. 1994 Apr; 123(4):485-91. PMID: 7511675.
    Citations: 49     Fields:    Translation:HumansAnimals
  37. Benzaquen LR, Nicholson-Weller A, Halperin JA. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med. 1994 Mar 01; 179(3):985-92. PMID: 8113689.
    Citations: 68     Fields:    Translation:HumansAnimalsCells
  38. Landa A, Laclette JP, Nicholson-Weller A, Shoemaker CB. cDNA cloning and recombinant expression of collagen-binding and complement inhibitor activity of Taenia solium paramyosin (AgB). Mol Biochem Parasitol. 1993 Aug; 60(2):343-7. PMID: 8232426.
    Citations: 10     Fields:    Translation:AnimalsCells
  39. Halperin JA, Taratuska A, Nicholson-Weller A. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J Clin Invest. 1993 May; 91(5):1974-8. PMID: 8486768.
    Citations: 40     Fields:    Translation:AnimalsCells
  40. Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol. 1993 Jan 15; 150(2):456-68. PMID: 8419478.
    Citations: 21     Fields:    Translation:HumansCells
  41. Halperin JA, Taratuska A, Rynkiewicz M, Nicholson-Weller A. Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). Blood. 1993 Jan 01; 81(1):200-5. PMID: 7678066.
    Citations: 9     Fields:    Translation:HumansCells
  42. Nicholson-Weller A, Halperin JA. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res. 1993; 12(3):244-57. PMID: 8288945.
    Citations: 43     Fields:    Translation:HumansAnimalsCells
  43. Finberg RW, White W, Nicholson-Weller A. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells. J Immunol. 1992 Sep 15; 149(6):2055-60. PMID: 1381394.
    Citations: 25     Fields:    Translation:HumansCells
  44. Mahoney JF, Urakaze M, Hall S, DeGasperi R, Chang HM, Sugiyama E, Warren CD, Borowitz M, Nicholson-Weller A, Rosse WF, et al. Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes. Blood. 1992 Mar 15; 79(6):1400-3. PMID: 1372185.
    Citations: 8     Fields:    Translation:HumansCells
  45. Laclette JP, Shoemaker CB, Richter D, Arcos L, Pante N, Cohen C, Bing D, Nicholson-Weller A. Paramyosin inhibits complement C1. J Immunol. 1992 Jan 01; 148(1):124-8. PMID: 1727860.
    Citations: 40     Fields:    Translation:AnimalsCells
  46. Nicholson-Weller A. Decay accelerating factor (CD55). Curr Top Microbiol Immunol. 1992; 178:7-30. PMID: 1385047.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  47. Yamamoto H, Blaas P, Nicholson-Weller A, Hänsch GM. Homologous species restriction of the complement-mediated killing of nucleated cells. Immunology. 1990 Aug; 70(4):422-6. PMID: 1697561.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  48. Marques MB, Weller PF, Parsonnet J, Ransil BJ, Nicholson-Weller A. Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus. J Clin Microbiol. 1989 Nov; 27(11):2451-4. PMID: 2808668.
    Citations: 17     Fields:    Translation:HumansCells
  49. Weller PF, Ackerman SJ, Nicholson-Weller A, Dvorak AM. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am J Pathol. 1989 Nov; 135(5):947-59. PMID: 2510521.
    Citations: 21     Fields:    Translation:HumansCells
  50. Lopez-Trascasa M, Bing DH, Rivard M, Nicholson-Weller A. Factor J: isolation and characterization of a new polypeptide inhibitor of complement C1. J Biol Chem. 1989 Sep 25; 264(27):16214-21. PMID: 2476439.
    Citations:    Fields:    Translation:HumansAnimals
  51. Halperin JA, Brugnara C, Nicholson-Weller A. Ca2+-activated K+ efflux limits complement-mediated lysis of human erythrocytes. J Clin Invest. 1989 May; 83(5):1466-71. PMID: 2708520.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  52. Lucey DR, Nicholson-Weller A, Weller PF. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A. 1989 Feb; 86(4):1348-51. PMID: 2919183.
    Citations: 58     Fields:    Translation:HumansCells
  53. Quigg RJ, Nicholson-Weller A, Cybulsky AV, Badalamenti J, Salant DJ. Decay accelerating factor regulates complement activation on glomerular epithelial cells. J Immunol. 1989 Feb 01; 142(3):877-82. PMID: 2464030.
    Citations: 25     Fields:    Translation:HumansAnimalsCells
  54. Nicholson-Weller A, Halperin JA. Mechanisms by which the erythrocyte protects itself from complement damage. Prog Clin Biol Res. 1989; 297:263-70; discussion 270-1. PMID: 2479950.
    Citations:    Fields:    Translation:HumansCells
  55. Halperin JA, Nicholson-Weller A. Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease. Complement Inflamm. 1989; 6(1):65-72. PMID: 2650991.
    Citations: 4     Fields:    Translation:Humans
  56. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med. 1989 Jan 01; 169(1):327-32. PMID: 2783333.
    Citations: 29     Fields:    Translation:HumansCells
  57. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood. 1989 Jan; 73(1):284-9. PMID: 2462937.
    Citations: 70     Fields:    Translation:HumansCells
  58. Hänsch GM, Weller PF, Nicholson-Weller A. Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C. Blood. 1988 Sep; 72(3):1089-92. PMID: 3416071.
    Citations: 20     Fields:    Translation:HumansCells
  59. Halperin JA, Nicholson-Weller A, Brugnara C, Tosteson DC. Complement induces a transient increase in membrane permeability in unlysed erythrocytes. J Clin Invest. 1988 Aug; 82(2):594-600. PMID: 3403718.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  60. Hu VW, Mazorow DL, Nicholson-Weller A, Shin ML. Enhancement of complement-mediated lysis of dithiothreitol-treated erythrocytes involves increased C9 insertion and polymerization. Mol Immunol. 1987 Aug; 24(8):887-96. PMID: 2821389.
    Citations:    Fields:    Translation:HumansCells
  61. Nicholson-Weller A, Zaia J, Raum MG, Coligan JE. Decay accelerating factor (DAF) peptide sequences share homology with a consensus sequence found in the superfamily of structurally related complement proteins and other proteins including haptoglobin, factor XIII, beta 2-glycoprotein I, and the IL-2 receptor. Immunol Lett. 1987 Apr; 14(4):307-11. PMID: 2438213.
    Citations:    Fields:    Translation:HumansCells
  62. Nicholson-Weller A, Russian DA, Austen KF. Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF). J Immunol. 1986 Aug 15; 137(4):1275-9. PMID: 3090145.
    Citations: 10     Fields:    Translation:HumansCells
  63. Shin ML, Hänsch G, Hu VW, Nicholson-Weller A. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9. J Immunol. 1986 Mar 01; 136(5):1777-82. PMID: 2419414.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  64. Hu VW, Nicholson-Weller A. Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization. Proc Natl Acad Sci U S A. 1985 Aug; 82(16):5520-4. PMID: 3860874.
    Citations: 7     Fields:    Translation:HumansCells
  65. Nicholson-Weller A, March JP, Rosen CE, Spicer DB, Austen KF. Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system. Blood. 1985 May; 65(5):1237-44. PMID: 2581636.
    Citations: 43     Fields:    Translation:HumansCells
  66. Nicholson-Weller A, Spicer DB, Austen KF. Deficiency of the complement regulatory protein, "decay-accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1985 Apr 25; 312(17):1091-7. PMID: 3845321.
    Citations: 37     Fields:    Translation:HumansCells
  67. Roberts WN, Wilson JG, Wong W, Jenkins DE, Fearon DT, Austen KF, Nicholson-Weller A. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria. J Immunol. 1985 Jan; 134(1):512-7. PMID: 2578050.
    Citations: 5     Fields:    Translation:HumansCells
  68. Edwards MS, Kasper DL, Nicholson-Weller A, Baker CJ. The role of complement in opsonization of GBS. Antibiot Chemother (1971). 1985; 35:170-89. PMID: 3901894.
    Citations: 3     Fields:    Translation:HumansCells
  69. Levy NJ, Nicholson-Weller A, Baker CJ, Kasper DL. Potentiation of virulence by group B streptococcal polysaccharides. J Infect Dis. 1984 Jun; 149(6):851-60. PMID: 6376652.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  70. Nicholson-Weller A, March JP, Rosenfeld SI, Austen KF. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci U S A. 1983 Aug; 80(16):5066-70. PMID: 6576376.
    Citations: 101     Fields:    Translation:HumansCells
  71. Eads ME, Levy NJ, Kasper DL, Baker CJ, Nicholson-Weller A. Antibody-independent activation of C1 by type Ia group B streptococci. J Infect Dis. 1982 Nov; 146(5):665-72. PMID: 6752296.
    Citations: 8     Fields:    Translation:Cells
  72. Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol. 1982 Jul; 129(1):184-9. PMID: 6211481.
    Citations: 166     Fields:    Translation:HumansAnimalsCells
  73. Daha MR, Bertina RM, Thompson J, Kauffmann RH, Nicholson-Weller A, Veltkamp JJ, Briët E. Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family. Clin Exp Immunol. 1982 Jun; 48(3):733-8. PMID: 6811172.
    Citations: 9     Fields:    Translation:Humans
  74. Markham RB, Nicholson-Weller A, Schiffman G, Kasper DL. The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. J Immunol. 1982 Jun; 128(6):2731-3. PMID: 7042846.
    Citations: 12     Fields:    Translation:AnimalsCells
  75. Edwards MS, Kasper DL, Jennings HJ, Baker CJ, Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol. 1982 Mar; 128(3):1278-83. PMID: 7035562.
    Citations: 77     Fields:    Translation:HumansAnimalsCells
  76. Nicholson-Weller A, Burge J, Austen KF. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a. J Immunol. 1981 Nov; 127(5):2035-9. PMID: 6913607.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  77. Nicholson-Weller A, Daha MR, Austen KF. Different functions for specific guinea pig IgG1 and IgG2 in the lysis of sheep erythrocytes by C4-deficient guinea pig serum. J Immunol. 1981 May; 126(5):1800-4. PMID: 7217667.
    Citations: 5     Fields:    Translation:AnimalsCells
  78. Burge J, Nicholson-Weller A, Austen KF. Isolation of the fourth component of guinea pig complement and its single polypeptide chain precursor from plasma. Mol Immunol. 1981 Jan; 18(1):47-54. PMID: 7266479.
    Citations: 1     Fields:    Translation:Animals
  79. Burge J, Nicholson-Weller A, Austen KF. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase. J Immunol. 1981 Jan; 126(1):232-5. PMID: 6778916.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  80. Edwards MS, Nicholson-Weller A, Baker CJ, Kasper DL. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med. 1980 May 01; 151(5):1275-87. PMID: 6989947.
    Citations: 80     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Nicholson-Weller's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (417)
Co-Authors (31)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.